CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Sofiva Genomics Co Ltd Company Snapshot
Sofiva Genomics Co Ltd operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Sofiva Genomics Co Ltd with three other companies in this sector in Taiwan: Medigen Biotechnology Corporation (2018 sales of 407.31 million Taiwanese Dollars [US$13.35 million] of which 83% was Drug Discovery), Genomics Biosci &Tech Co Ltd (438.69 million Taiwanese Dollars [US$14.38 million] ), and Welgene Biotech Co Ltd (384.43 million Taiwanese Dollars [US$12.60 million] ).

Sales Analysis. Sofiva Genomics Co Ltd reported sales of 459.40 million Taiwanese Dollars (US$15.06 million) for the year ending December of 2018. This represents an increase of 8.4% versus 2017, when the company's sales were 423.94 million Taiwanese Dollars. Sales at Sofiva Genomics Co Ltd have increased during each of the previous five years (and since 2013, sales have increased a total of 198%).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Sofiva Genomics Co Ltd
  Stock Performance Chart for Sofiva Genomics Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (11/15/2019): 81.50
(Figures in Taiwanese Dollars)
1 Week 1.6%   13 Weeks 1.4%  
4 Weeks -12.0%   52 Weeks 0.6%  
 
Sofiva Genomics Co Ltd Key Data:
  Ticker: 6615 Country: Taiwan
  Exchanges: TAI Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 459,396,000
(Year Ending Jan 2019).
Employees: N/A
  Currency: Taiwanese Dollars Market Cap: 1,724,442,200
  Fiscal Yr Ends: December Shares Outstanding: 21,158,800
  Share Type: Gu Closely Held Shares: 10,578,000
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.